NovoLog Observation Trial in Subjects With Type 1 and Type 2 Diabetes
Status:
Completed
Trial end date:
2005-03-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in the United States of America (USA). The aim of this trial is to
assess control of blood sugar, safety, and patient acceptance of insulin aspart compared to
insulin lispro, both in insulin pumps, in standard clinical practice.